DHODH and melanoma: Building on our prior findings that pharmacological DHODH inhibition induces mitochondrial oxidative stress and pyroptotic cell death in melanoma—alongside recruitment of NK cells—we previously developed EA6, a next-generation DHODH inhibitor with enhanced potency.